StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Get Free Report) in a report released on Tuesday. The brokerage set a “sell” rating on the stock.
Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.
Check Out Our Latest Stock Report on Streamline Health Solutions
Streamline Health Solutions Trading Down 1.0 %
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last posted its earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The business had revenue of $4.48 million for the quarter.
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Featured Articles
- Five stocks we like better than Streamline Health Solutions
- How to Invest in Blue Chip Stocks
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- ETF Screener: Uses and Step-by-Step Guide
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.